Prismasol Bgk4/2.5 NDC 24571-105

Product information

Brand name (proprietary)

Prismasol Bgk4/2.5Suffix: BGK4/2.5

Generic name (nonproprietary)

calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride

Active ingredients

Calcium chloride — 3.68 g/LMagnesium chloride — 3.05 g/LAnhydrous dextrose — 20 g/LLactic acid — 5.4 g/LSodium chloride — 6.46 g/LSodium bicarbonate — 3.09 g/LPotassium chloride — .314 g/L

Dosage form

Injection

Route

Intravenous

Labeler

Vantive US Healthcare LLC

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 021703

Marketing start

Oct 25, 2006

Listing expires

Dec 31, 2027

Other FDA classes

Acidifying Activity (Mechanism)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)

Identifiers

Product ID 24571-105_3744e93f-f360-485a-bad4-948c168127c2SPL ID 3744e93f-f360-485a-bad4-948c168127c2SPL set ID 7f675fee-8940-4ece-bb0c-75ac79d8708cUNII 33X04XA5AT, 8MDF5V39QO, M4I0D6VV5M, 5SL0G7R0OK, 660YQ98I10, GR686LBA74, 02F3473H9O, 451W47IQ8X

Pharmacologic class

Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N424571010506 followed by a unit qualifier and the quantity Copy

Package 24571-0105-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 021703

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.